{"favorite_id": 4067, "calc_type": "calculator", "dosing": false, "full_title_en": "YEARS Algorithm for Pulmonary Embolism (PE)", "short_title_en": "YEARS Algorithm", "medium_description_en": "Helps rule out pulmonary embolism; also validated in pregnant patients with clinically suspected PE.", "short_description_en": "PE rule-out.", "before_use": "", "instructions_en": "<p>Use in hemodynamically stable patients &ge;18 years old.</p>\n<p>Take note of the following exclusion criteria:</p>\n<ul>\n<li>Treatment with therapeutic doses of anticoagulants initiated 24 hours or more before eligibility assessment.</li>\n<li>Life expectancy less than 3 months.</li>\n<li>Geographic inaccessibility precluding follow-up.</li>\n<li>Pregnancy (be sure to use pregnancy-adapted YEARS algorithm in the calc).</li>\n<li>Allergy to intravenous contrast agent.</li>\n</ul>", "slug": "years-algorithm-for-pulmonary-embolism-pe", "logic_language": "javascript", "md5": "a5c7d27a3e53b17a060f9bfeee263505", "cmeVersion": "4067.1", "cmeReleaseDate": "2022-10-07 00:00:00+00+00", "cmeEndDate": "2025-10-03 00:00:00+00+00", "cmeLastReviewed": "2022-10-03 00:00:00+00+00", "search_abbreviation_en": ["acute PE", "ctpa", "years score", "years algorithm", "years"], "seo": {"meta_description_en": "The YEARS Algorithm for PE helps rule out pulmonary embolism (not externally validated).", "keywords_en": "acute pulmonary embolism, Pulmonary embolism, PE, computed tomography pulmonary angiography, CTPA, deep venous thrombosis, symptomatic venous thromboembolism, VTE, DVT, hemoptysis, hemoptysis, YEARS algorithm, d-dimer cutoff, Wells\u2019 criteria, contrast-induced nephropathy, vascular medicine, "}, "content": {"reviewer": {"expert_name": []}, "related_resources": {"videos": [], "sdm_tool": [], "teaching": [], "interests": [], "guidelines": [], "mdcalc_rating": [], "partner_contact": []}, "how_to_use": {"use_case_en": "<ul>\n<li>Hemodynamically stable patients &ge;18 years old with clinically suspected acute pulmonary embolism (PE).</li>\n<li>Note: this study included patients with suspected acute PE in both inpatient and outpatient settings.</li>\n<li>Note that the original study did not include patients who:\n<ul>\n<li>Were treated with therapeutic doses of anticoagulants initiated&nbsp;24 hours or more before eligibility assessment.</li>\n<li>Have a life expectancy less than 3 months or geographic inaccessibility precluding follow up.</li>\n<li>Have an allergy to intravenous contrast agent.</li>\n</ul>\n</li>\n</ul>", "pearls_pitfalls_en": "<ul>\n<li>Consists of the three most predictive criteria of the <calculator id=\"115\">Wells' Score for PE</calculator>: clinical signs of deep vein thrombosis (DVT), hemoptysis, and whether PE is the most likely diagnosis.</li>\n<li>Also incorporates variable D-dimer thresholds, depending on the number of criteria fulfilled.</li>\n<li>In patients with no YEARS items and D-dimer &lt;1,000 ng/mL, or with one or more YEARS items and D-dimer &lt;500 ng/mL,&nbsp;PE was considered excluded. All other patients had CT pulmonary angiogram (CTPA).</li>\n</ul>", "why_use_en": "<ul>\n<li>Reduces use of CTPA by 14% compared with the current standard algorithm (absolute reduction) and by 8.7% compared with the age-adjusted D-dimer threshold, such that patients younger than 50 years also benefit from the YEARS algorithm.</li>\n<li>Provides for simple and efficient diagnostic management of patients with suspected PE, and is more compatible with the demands of clinical practice.</li>\n<li>Reduces false positives, overdiagnosis, and overutilization of CTPA investigations in all age groups, in addition to reducing unnecessary exposure to ionizing radiation.</li>\n</ul>"}, "next_steps": {"advice_en": "<ul>\n<li>PE was excluded (and CTPA deemed unnecessary) in patients who who fell below the D-dimer thresholds set by the YEARS algorithm.</li>\n<li>3-month incidence of venous thromboembolism (VTE) of patients who did not undergo CTPA was 0.43%. This is similar to the traditional two-tier <calculator id=\"115\">Wells' Score</calculator> (0.34%).</li>\n</ul>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p>Refer to decision tree:</p>\n<p><img src=\"https://cdn-web-img.mdcalc.com/years-tree.png\" width=\"967\" height=\"1005\" alt=\"\" /></p>\n<p>Adapted from <a href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa1813865\" target=\"_blank\" rel=\"noopener\">Van der Pol 2019</a>.</p>\n<p>Take note of the following exclusion criteria:</p>\n<ul>\n<li>Treatment with therapeutic doses of anticoagulants initiated 24 hours or more before eligibility assessment.</li>\n<li>Life expectancy less than 3 months.</li>\n<li>Geographic inaccessibility precluding follow-up.</li>\n<li>Pregnancy (be sure to use pregnancy-adapted YEARS algorithm in the calc).</li>\n<li>Allergy to intravenous contrast agent.</li>\n</ul>", "more_info_en": "", "evidence_based_medicine_en": "<p>Original YEARS study:</p>\n<ul>\n<li>Prospective cohort study conducted in 12 hospitals across the Netherlands in hemodynamically stable patients with suspected pulmonary embolism.</li>\n<li>The algorithm was applied by first evaluating the presence of YEARS items: clinical signs of DVT, hemoptysis, or PE most likely diagnosis. All patients underwent a D-dimer test. In patients with no YEARS items and D-dimer &lt;1,000 ng/mL, PE was excluded and no CTPA was performed. In patients with one or more YEARS items and D-dimer &lt;500 ng/mL, PE was excluded and no CTPA was performed. All other patients received CTPA.</li>\n<li>Primary outcome was number of venous thromboembolism (VTE) events during the 3 months after PE was excluded and was analyzed using per protocol approach. The secondary outcome was the number of required CTPA compared to Wells&rsquo; Score for PE, analyzed using an intention-to-treat analysis.</li>\n<li>3,616 patients with clinically suspected PE were screened, and 3,465 were included in the study.</li>\n<li>18 (0.61%) were diagnosed with a symptomatic venous thromboembolism during the 3 month follow up. 6 of those patients had fatal PE (0.21%). &nbsp;</li>\n<li>2,946 patients (85%) were ruled out for PE using the algorithm. Of 1,629 patients who were ruled out without CTPA, 7 (0.43%) had symptomatic venous thromboembolism during the 3 month follow up, 2 of which were fatal.</li>\n<li>1,317 (15%) of patients were managed with CTPA. Of those patients, 11 (0.84%) had symptomatic venous thromboembolism during 3 month follow up, 4 of which were fatal.</li>\n<li>When compared to Wells&rsquo; Score with fixed D-dimer of 500 ng/mL, the YEARS algorithm reduced CTPA by 14% across all ages and subgroups.</li>\n<li>It appears as though the binary D-dimer cutoffs used in the YEARS trial reduced the rate of CTPA when compared to using age adjusted D-dimer.</li>\n<li>If age adjusted D-dimer was applied, the YEARS algorithm would have led to an absolute reduction of CTPA by only 8.7% compared to 14% using the binary cutoffs of the YEARS algorithm.</li>\n<li>Age adjusted D-dimer, defined as age x 10 in patients over the age of 50, has been prospectively validated to be safe and reduce the number of CTPA in patients low risk for PE.</li>\n<li>Take note of the following exclusion criteria:\n<ul>\n<li>Treatment with therapeutic doses of anticoagulants initiated 24 hours or more before eligibility assessment.</li>\n<li>Life expectancy less than 3 months.</li>\n<li>Geographic inaccessibility precluding follow-up.</li>\n<li>Pregnancy (be sure to use pregnancy-adapted YEARS algorithm in the calc).</li>\n<li>Allergy to intravenous contrast agent.</li>\n</ul>\n</li>\n</ul>\n<p>Subgroup analysis:</p>\n<ul>\n<li>The authors of the original YEARS study published a subgroup analysis of the patients 50 years and older and compared this subgroup to the age adjusted d-dimer cutoffs.</li>\n<li>In the YEARS study, 1,651 (48%) patients aged 50 years and older were managed without CTPA.</li>\n<li>If the age adjusted D-dimer cutoffs had been applied to the YEARS subgroup, 1,627 patients (47%) would have been managed without CTPA. This adjustment lead to an absolute increase of CTPA by 0.69%. This increase in CTPA did not result in a higher sensitivity but rather would have missed 4 PEs in patients that were confirmed on CTPA as they had one or more YEARS items and D-dimer &gt;500 ng/mL in the original YEARS study.</li>\n<li>The authors concluded in the YEARS cohort, there was no added value of implementing age adjusted D-dimer in the YEARS algorithm.</li>\n</ul>", "references_list": {"Validation": [{"text": "Kabrhel C, Van hylckama vlieg A, Muzikanski A, et al. Multicenter Evaluation of the YEARS Criteria in Emergency Department Patients Evaluated for Pulmonary Embolism. Acad Emerg Med. 2018;25(9):987-994.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/29603819"}, {"text": "Freund Y, Chauvin A, Jimenez S, et al. Effect of a diagnostic strategy using an elevated and age-adjusted d-dimer threshold on thromboembolic events in emergency department patients with suspected pulmonary embolism: a randomized clinical trial. JAMA. 2021;326(21):2141-2149.", "href": "https://jamanetwork.com/journals/jama/fullarticle/2786829?guestAccessKey=526b2220-c362-4e03-abb8-d2ddf1df3fcf&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=etoc&utm_term=120721"}], "Outcomes": [], "Validations": [], "Original/Primary Reference": [{"text": "Van der Hulle T, Cheung WY, Kooij S, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet. 2017;", "href": "https://www.ncbi.nlm.nih.gov/pubmed/28549662 "}], "Other References": [{"text": "Van der Pol LM, Van der Hulle T, Cheung YW, et al. No added value of the age-adjusted D-dimer cut-off to the YEARS algorithm in patients with suspected pulmonary embolism. J Thromb Haemost. 2017;15(12):2317-2324.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/28941051"}, {"text": "Righini M, Van es J, Den exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311(11):1117-24.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/24643601"}, {"text": "Van der pol LM, Tromeur C, Bistervels IM, et al. Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism. N Engl J Med. 2019;380(12):1139-1149.", "href": "https://www.nejm.org/doi/full/10.1056/NEJMoa1813865"}], "Clinical Practice Guidelines": [], "Manufacturer Website": []}}, "creator": [{"qa_en": "", "approved": false, "name": "Dr. Tom van der Hulle", "creator_info": {"deceased": null, "about_en": "<p>Tom van der Hulle, MD, is an internist in the department of thrombosis and hemostasis at Leiden University Medical Centre in Leiden, Netherlands. His primary research interests involve hematology, oncology, and pulmonology.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-tom-van-der-hulle.png", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=van+der+Hulle+T%5Bau%5D"}}, {"qa_en": "", "approved": false, "name": "Dr. Menno Huisman", "creator_info": {"deceased": null, "about_en": "<p>Menno Huisman, MD, PhD, FESC, is a professor of medicine in the department of medicine - thrombosis and hemostasis at Leiden University Medical Center in The Netherlands. He is an internist with specialty in cardiovascular medicine. Dr. Huisman\u2019s primary research is focused on the clinical diagnosis and treatment of venous and arterial thromboembolic disorders.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/Dr-Menno-Huisman.jpg", "pubmedLink": "https://pubmed.ncbi.nlm.nih.gov/?term=Huisman+MV+%5Bauthor%5D"}}], "contributor": {"expert_name": [{"description": "<p>Matthew Negaard, MD, is a current third-year emergency medicine resident at the University of Iowa. He grew up in Sioux City, Iowa and attended Northwestern College in Orange City, Iowa for his undergraduate education. Dr. Negaard received his medical degree from the University of Iowa Carver College of Medicine where he began to develop an interest in emergency medicine and sports medicine. He has continued to develop and expand his interest in those fields as well as medical education through clinical research and evidence-based practice activities. He plans to pursue a sports medicine fellowship upon completion of his residency.</p>", "firstName": "Matthew", "img": "https://cdn-web-img.mdcalc.com/people/matthew-negaard.jpg", "lastName": "Negaard", "name": "Matthew Negaard, MD", "target": "matthew-negaard", "signedCOI": true, "hasDisclosure": []}]}}, "input_schema": [{"type": "toggle", "name": "pregnant", "conditionality": "", "optional": false, "default": 0, "label_en": "<p>Pregnant patient</p>", "show_points": false, "tips_en": "", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}]}, {"type": "subheading", "subheading": "<p>YEARS items</p>", "subheading_instructions": ""}, {"type": "toggle", "name": "dvt", "conditionality": "", "optional": false, "default": null, "label_en": "<p>Clinical signs of DVT</p>", "show_points": false, "tips_en": "", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}]}, {"type": "radio", "label_en": "<p>Compression ultrasonography of symptomatic leg</p>", "name": "comp", "default": null, "show_points": false, "optional": false, "conditionality": "pregnant == 1 && dvt == 1", "tips_en": "", "options": [{"label": "Abnormal", "value": 0}, {"label": "Normal", "value": 1}]}, {"type": "toggle", "name": "hemoptysis", "conditionality": "", "optional": false, "default": null, "label_en": "<p>Hemoptysis</p>", "show_points": false, "tips_en": "", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}]}, {"type": "toggle", "name": "likely", "conditionality": "", "optional": false, "default": null, "label_en": "<p>PE most likely diagnosis</p>", "show_points": false, "tips_en": "", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}]}, {"type": "subheading", "subheading": "<p>D-dimer</p>", "subheading_instructions": ""}, {"type": "radio", "label_en": "<p>D-dimer &ge;500 ng/mL</p>", "name": "dimer500", "default": null, "show_points": false, "optional": false, "conditionality": "dvt + hemoptysis + likely > 0", "tips_en": "", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}]}, {"type": "subheading", "subheading": "<p>D-dimer</p>", "subheading_instructions": ""}, {"type": "radio", "label_en": "<p>D-dimer &ge;1,000 ng/mL</p>", "name": "dimer1000", "default": null, "show_points": false, "optional": false, "conditionality": "dvt == 0 && hemoptysis == 0 && likely == 0", "tips_en": "", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}]}], "chief_complaint_en": ["Chest Pain", "Cough", "Extremity Edema", "Palpitations", "Shortness of Breath", "Syncope"], "specialty_en": ["Cardiology", "Critical Care", "Emergency Medicine", "Hospitalist Medicine", "Pulmonology"], "purpose_en": ["Algorithm", "Diagnosis"], "system_en": ["Cardiac", "Respiratory", "Vascular"], "disease_en": ["Pulmonary Embolism"], "related_calcs": [{"calcId": 115, "short_title_en": "Wells' Score for PE", "slug": "wells-criteria-pulmonary-embolism"}, {"calcId": 1750, "short_title_en": "Geneva Score (Revised)", "slug": "geneva-score-revised-pulmonary-embolism"}, {"calcId": 10138, "short_title_en": "Age-Adjusted D-dimer", "slug": "age-adjusted-d-dimer-venous-thromboembolism-vte"}]}